ASAP’s 2023 Collaborative Meetings welcomed core leadership and trainees from each CRN team to create a space to make connections, share their work, and spark new ideas that spanned career levels, disciplines, and continents. Each event showcased participants who received awards for their work that they presented at the meeting.
Read NPR's coverage of GP2's historic GBA1 finding. This article by Jon Hamilton includes interviews with ASAP's Managing Director, Dr. Ekemini A. U. Riley, and lead GP2 study researchers, Andy Singleton and Sara Bandres-Ciga.
Dr. Ekemini A. U. Riley, managing director of ASAP, joins PBS NewsHour to discuss findings from the GBA1 discovery and the power of collaborative, open science to unlock discoveries for populations traditionally underrepresented in research.
The Guardian Nigeria reports on GP2 and its collaboration with the University of Lagos (UNILAG) to uncover a genetic variant that increases the risk of PD in Africans and African admixed populations.
A Parkinson’s ‘game changer,’ backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments
STAT highlights how The Parkinson’s Progression Markers Initiative (PPMI) recently discovered how αSyn-SAA could be a novel tool for precision medicine approaches, earlier intervention, and improved clinical trial design for Parkinson's disease.
Exclusive: Google Cofounder Sergey Brin Has Quietly Donated More Than $1 Billion Toward Parkinson’s Disease
Forbes Magazine spotlights the ASAP initiative and the collective effort to accelerate the pace of discovery and inform the path to a cure for Parkinson's disease.